Direct access from general practice to transvaginal ultrasound for early detection of ovarian cancer: a feasibility study

References

• Danish Gynecological Cancer Database [Internet]. Ovariecancer retningslinjer 2016 [Ovarian cancer guideline]. Copenhagen (Denmark): DGCD; 2019 [cited 2019 February 3]. Available from: http://www.dgcg.dk/index.php/guidelines/ovariecancer-guidelines
   Google Scholar
• Danish Gynecological Cancer Database [Internet]. National report 2015/2016. Copenhagen (Denmark): DGCD; 2019 [cited 2019 February 3]. Available from: http://www.dgcg.dk/images/rsrapport_DGCD_2015-16_endelig_anonymiseret.pdf
   Google Scholar
• Danish National Board of Health [Internet]. Pakkeforløb for kraeft i aeggestokkene [The cancer patient pathway for ovarian cancer]. Copenhagen (Denmark): DGCD; 2019 [cited 2019 February 12]. Available from: https://www.sst.dk/da/sygdom-og-behandling/kraeft/pakkeforloeb/∼/media/765A142BC73446399C769A5D8B54C3DC.ashx
   Google Scholar
• Rai N, Nevin J, Downey G, et al. Outcomes following implementation of symptom triggered diagnostic testing for ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 2015;187:64–69.
   PubMed Web of Science ®Google Scholar
• Baun ML, Jensen H, Falborg AZ, et al. Ovarian cancer suspicion, urgent referral and time to diagnosis in Danish general practice: a population-based study. Fam Pract. 2019;36(6):751–757.
   PubMed Web of Science ®Google Scholar
• Balasubramaniam K, Ravn P, Larsen PV, et al. Specific and unspecific gynecological alarm symptoms–prevalence estimates in different age groups: a population-based study. Acta Obstet Gynecol Scand. 2015;94(2):191–197.
   PubMed Web of Science ®Google Scholar
• Hamilton W, Peters TJ, Bankhead C, et al. Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ. 2009;339(2):b2998.
   PubMed Web of Science ®Google Scholar
• Jacobs IJ, Menon U, Ryan A, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2016;387(10022):945–956.
   PubMed Web of Science ®Google Scholar
• Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA. 2011;305(22):2295–2303.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence: Guidance 2011 [Internet]. Ovarian cancer: recognition and initial management. London (UK): NICE; 2011 [cited 2018 September 15]. Available from: https://www.nice.org.uk/guidance/cg122
   Google Scholar
• Jacobs IJ, Menon U. Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics. 2004;3(4):355–366.
   PubMed Web of Science ®Google Scholar
• Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10(4):327–340.
   PubMed Web of Science ®Google Scholar
• Pavlik EJ, van Nagell JR. Jr. Early detection of ovarian tumors using ultrasound. Womens Health. 2013;9(1):39.
   Google Scholar
• Din bopael er afgørende: Så lang er ventetiden hos speciallaegen [Your address determines the waiting time for an appointment with a specialist] [Internet]. Odense (Denmark): TV2 FYN; 2019 [cited 2019 January 10]. Available from: https://www.tv2fyn.dk/artikel/bopaelen-er-afgoerende-saa-lang-er-ventetiderne-hos-speciallaeger
   Google Scholar
• Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109(2):221–227.
   PubMed Web of Science ®Google Scholar
• Timmerman D, Testa AC, Bourne T, et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol. 2008;31(6):681–690.
   PubMed Web of Science ®Google Scholar
• Timmerman D, Ameye L, Fischerova D, et al. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ. 2010;341(1):c6839.
   PubMed Web of Science ®Google Scholar
• Sayasneh A, Wynants L, Preisler J, et al. Multicentre external validation of IOTA prediction models and RMI by operators with varied training. Br J Cancer. 2013;108(12):2448–2454.
   PubMed Web of Science ®Google Scholar
• Kaijser J, Sayasneh A, Van Hoorde K, et al. Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(3):449–462.
   PubMed Web of Science ®Google Scholar
• Alcazar JL, Pascual MA, Olartecoechea B, et al. IOTA simple rules for discriminating between benign and malignant adnexal masses: prospective external validation. Ultrasound Obstet Gynecol. 2013;42(s1):30–71.
   Google Scholar
• Buys SS, Partridge E, Greene MH, et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 2005;193(5):1630–1639.
   PubMed Web of Science ®Google Scholar
• Gilbert L, Basso O, Sampalis J, et al. Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project. Lancet Oncol. 2012;13(3):285–291.
   PubMed Web of Science ®Google Scholar
• Andersen MR, Lowe KA, Goff BA. Value of symptom-triggered diagnostic evaluation for ovarian cancer. Obstet Gynecol. 2014;123(1):73–79.
   PubMed Web of Science ®Google Scholar
• Chang SJ, Bristow RE. Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining ‘optimal’ residual disease. Gynecol Oncol. 2012;125(2):483–492.
   PubMed Web of Science ®Google Scholar
• Sibbald B. Direct access to diagnostic services. Br J Gen Pract. 2009;59(562):e144–e145.
   PubMed Web of Science ®Google Scholar
• Smith CF, Tompson AC, Jones N, et al. Direct access cancer testing in primary care: a systematic review of use and clinical outcomes. Br J Gen Pract. 2018;68(674):e594–e603.
   PubMed Web of Science ®Google Scholar
• Vine MF, Calingaert B, Berchuck A, et al. Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol. 2003;90(1):75–82.
   PubMed Web of Science ®Google Scholar
• Basnyat PS, Gomez KF, West J, et al. Nurse-led direct access endoscopy clinics: the future? Surg Endosc. 2002;16(1):166–169.
   PubMed Web of Science ®Google Scholar
• Wilkes S, Murdoch A, Steen N, et al. Open access tubal assessment for the initial management of infertility in general practice (the OATS trial): a pragmatic cluster randomised controlled trial. Br J Gen Pract. 2009;59(562):329–335.
   PubMed Web of Science ®Google Scholar
• Goff BA, Lowe KA, Kane JC, et al. Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability. Gynecol Oncol. 2012;124(2):230–235.
   PubMed Web of Science ®Google Scholar